Recurrent and founder mutations in the Netherlands Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation

被引:10
|
作者
Aalberts, J. J. J. [2 ]
Schuurman, A. G. [1 ]
Pals, G. [3 ]
Hamel, B. J. C. [4 ]
Bosman, G. [1 ]
Hilhorst-Hofstee, Y. [5 ]
Barge-Schaapveld, D. Q. C. M. [6 ]
Mulder, B. J. M. [7 ]
van den Berg, M. P. [2 ]
van Tintelen, J. P. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Ctr Thorax, NL-9700 RB Groningen, Netherlands
[3] Vrije Univ Amsterdam, Dept Clin Genet, Med Ctr, Amsterdam, Netherlands
[4] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands
[5] Leiden Univ, Dept Clin Genet, Med Ctr, NL-2300 RA Leiden, Netherlands
[6] Univ Amsterdam, Dept Clin Genet, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands
[7] Univ Amsterdam, Dept Cardiol, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands
关键词
Marfan Syndrome/genetics; Microfilament Proteins; Mutation; Missense; Netherlands; TGF-BETA ACTIVATION; 1009; PROBANDS; MOUSE MODEL; GENE; FIBRILLINOPATHIES; PATHOGENESIS; DISORDERS;
D O I
10.1007/BF03091743
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Methods. Marfan syndrome (MFS) is a heritable connective tissue disorder usually caused by a mutation in the fibrillin 1 (FBN1) gene. Typical characteristics of MPS that have been described include dolichostenomelia, ectopia lentis and aortic root dilatation. However, there is great clinical variability in the expression of the syndrome's manifestations, both between and within families. Here we discuss the clinical variability of MFS by describing a large four-generation Dutch family with MFS. Results. Nineteen individuals of one family with a single missense FBN1 mutation (c.7916A>G) were identified. The same mutation was found in one unrelated person. Clinical variability was extensive and not all mutation carriers fulfilled the diagnostic criteria for MFS. Some patients only expressed mild skeletal abnormalities, whereas aortic root dilation was present in eight patients, an acute type A aortic dissection was recorded in two other patients, and a mitral valve prolapse was present in eight patients. In some patients cardiac features were not present on initial screening, but did however develop over time. Conclusion. MFS is a clinically highly variable syndrome, which means a meticulous evaluation of suspected cases is crucial. Mutation carriers should be re-evaluated regularly as cardiovascular symptoms may develop over time. (Neth Heart J 2010;18:85-9.)
引用
收藏
页码:85 / 89
页数:5
相关论文
共 50 条
  • [21] Mutation screening of all 65 exons of the fibrillin-1 gene in 60 patients with Marfan syndrome: Report of 12 novel mutations
    Hayward, C
    Porteous, ME
    Brock, DJH
    HUMAN MUTATION, 1997, 10 (04) : 280 - 289
  • [22] Identification of a novel lethal fibrillin-1 gene mutation in a Chinese Marfan family and correlation of 3' fibrillin-1 gene mutations with phenotype
    Gao Ling-gen
    Zhang Lin
    Song Lei
    Wang Hu
    Chang Qian
    Wu Yong-bo
    Hui Ru-tai
    Zhou Xian-liang
    CHINESE MEDICAL JOURNAL, 2010, 123 (20) : 2874 - 2878
  • [23] Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndrome
    Hung, Chia-Cheng
    Lin, Shin-Yu
    Lee, Chien-Nan
    Cheng, Hui-Yu
    Lin, Shuan-Pei
    Chen, Ming-Ren
    Chen, Chih-Ping
    Chang, Chien-Hui
    Lin, Chiou-Ya
    Yu, Chih-Chieh
    Chiu, Hsin-Hui
    Cheng, Wen-Fang
    Ho, Hong-Nerng
    Niu, Dau-Ming
    Su, Yi-Ning
    ANNALS OF HUMAN GENETICS, 2009, 73 : 559 - 567
  • [24] Novel exon skipping mutation in the fibrillin-1 gene: Two 'hot spots' for the neonatal Marfan syndrome
    Booms, P
    Cisler, J
    Mathews, KR
    Godfrey, M
    Tiecke, F
    Kaufmann, UC
    Vetter, U
    Hagemeier, C
    Robinson, PN
    CLINICAL GENETICS, 1999, 55 (02) : 110 - 117
  • [25] Two novel mutations of fibrillin-1 gene correlate with different phenotypes of Marfan syndrome in Chinese families
    Zhao, Feng
    Pan, Xinyuan
    Zhao, Kanxing
    Zhao, Chen
    MOLECULAR VISION, 2013, 19 : 751 - 758
  • [26] Characterization of 4 novel fibrillin-1 (FBN1) mutations in Marfan syndrome and related disorders.
    Yuan, B
    Thull, DL
    Thomas, JP
    Pyeritz, RE
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A352 - A352
  • [27] Two rare missense mutations in the fibrillin-1 gene associated with atypical cardiovascular manifestations in a Chinese patient affected by Marfan syndrome
    Zhang, Miao
    Zhou, Yaqi
    Peng, Yang
    Jin, Lijun
    MOLECULAR MEDICINE REPORTS, 2018, 18 (01) : 877 - 881
  • [28] Central Nervous System Abnormalities in Two Cases With Neonatal Marfan Syndrome With Novel Mutations in the Fibrillin-1 Gene
    Barnett, Christopher P.
    Wilson, Gregory J.
    Chiasson, David A.
    Gross, Gil J.
    Hinek, Aleksander
    Hawkins, Cynthia
    Chitayat, David
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A (09) : 2409 - 2412
  • [29] Three novel mutations in the fibrillin gene (FBN1) in Marfan syndrome patients
    Arbustini, E
    Fasani, R
    Grasso, M
    Diegoli, M
    Pilotto, A
    Banchieri, N
    Porcu, E
    Sapone, L
    Magani, F
    Larizza, D
    Cetta, G
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 60 - 60
  • [30] Thirteen novel fibrillin-1 mutations detected using heteroduplex analysis In a screen of 44 individuals with classical Marfan syndrome.
    Bernard, LE
    Huntsman, D
    Rahemtullah, A
    McGillivray, BC
    Langlois, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A326 - A326